This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Burkman RT et al. (2003) Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Developement Women’s Contraceptive and Reproductive Experiences Study. Fertil Steril 79: 844–851
Dayal M, Barnhart KT (2001) Noncontraceptive benefits and therapeutic uses of the oral contraceptive pill. Semin Reprod Endocrino 119: 295–303
Fathalla MF (1971) Incessant ovulation - a factor in ovarian neoplasia? Lancet 2: 163
Kubik CJ (1986) Luteal phase dysfunction following ovulation induction. Semin Reprod Endocrinol 4: 293–299
Modan B et al. (1998) Cancer incidence in a cohort of infertile women. Am J Epidemio1147: 1038–1042
Mosgaard BJ et al. (1997) Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 67: 1005–1012
Venn A et al. (1999) Risk of cancer after use of fertility drugs with in vitro fertilisation. Lancet 354: 1586–1590
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kleinstein, J. (2003). Was erhöht das Karzinomrisiko: Sterilität oder Sterilitätstherapie?. In: Gießener Gynäkologische Fortbildung 2003. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07492-3_25
Download citation
DOI: https://doi.org/10.1007/978-3-662-07492-3_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-04757-5
Online ISBN: 978-3-662-07492-3
eBook Packages: Springer Book Archive